Discontinuation report ARZERRA

Last updated on 2019-03-12 History
Report ID 78215
Drug Identification Number 02381559
Brand name ARZERRA
Common or Proper name ARZERRA 100MG VIALS 5ML X 3
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) Ofatumumab
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5ml x3
ATC code L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-03-11
Actual discontinuation date 2019-03-11
Remaining supply date 2019-03-11
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-03-12 English Compare
v3 2019-03-11 French Compare
v2 2019-03-11 English Compare
v1 2019-03-11 English Compare